NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02958111,Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT02958111,CAN,UNKNOWN,"This is an randomized, controlled, multicenter phase 3 clinical trial. The purpose of this study is to evaluate the efficacy and safety of single-agent capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC).",NO,Nasopharyngeal Carcinoma,DRUG: Capecitabine,"Progression-free survival, 3 years","Overall survival, 3 years|Distant failure-free survival, 3 years|Locoregional failure-free survival, 3 years|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0, 1 year|Quality of life (QOL) as assessed by EORTC quality of life questionnaire(QLQ)-C30, 1 year",,Sun Yat-sen University,"Tongji Hospital|Wuhan Union Hospital, China|Peking University|Air Force Military Medical University, China|Second Affiliated Hospital of Soochow University|West China Hospital|The First Affiliated Hospital of Guangdong Pharmaceutical University|First People's Hospital of Foshan|Fifth Affiliated Hospital, Sun Yat-Sen University|Cancer Hospital of Guizhou Province|Xiangya Hospital of Central South University|First Affiliated Hospital of Zhejiang University|Jilin Provincial Tumor Hospital|Henan Cancer Hospital|Hunan Cancer Hospital|The First Affiliated Hospital of Xiamen University|Cancer Hospital of Guangxi Medical University",ALL,"ADULT, OLDER_ADULT",PHASE3,406,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-FXY-075,2017-01,2021-12,2023-12,2016-11-08,,2019-06-12,"Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China",
